LR Health & Beauty SE Announces Major Bond Restructuring Agreement

LR Health & Beauty SE has reached a pivotal agreement with bondholders and its shareholder to restructure its 2024/2028 bonds. This includes a EUR 20 million capital injection, with EUR 10 million committed to equity and EUR 10 million allocated to new senior bonds. This move aims to significantly streamline the company's debt structure.

The restructuring involves a senior secured debt arrangement totaling EUR 62.5 million, with various tranches ranking equally. Additionally, junior bonds have been set at EUR 27.5 million. The bondholders have agreed not to demand immediate repayments during the lock-up period ending in April 2026.

The restructuring is subject to final approval from bondholders and shareholders, with completion expected by the end of April 2026.